Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Nucl Cardiol. 2007 Apr;14(2):207–214. doi: 10.1016/j.nuclcard.2006.12.328

Figure 3.

Figure 3

Comparison of normalized transmural MBF before and 24 weeks after TMR in both the control and treated regions at rest (A) and during peak dobutamine dose (B). There was no change in myocardial perfusion at rest, but during dobutamine, there was increased MBF in the treated region.